POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 84 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,049,171 | +43.5% | 307,222 | +94.9% | 0.00% | – |
Q2 2023 | $1,428,018 | -49.5% | 157,618 | -59.5% | 0.00% | – |
Q1 2023 | $2,829,950 | -6.6% | 389,264 | -6.4% | 0.00% | – |
Q4 2022 | $3,031,014 | +117.4% | 415,777 | +130.5% | 0.00% | – |
Q3 2022 | $1,394,000 | +130.4% | 180,362 | +103.0% | 0.00% | – |
Q2 2022 | $605,000 | -31.9% | 88,833 | -20.4% | 0.00% | – |
Q1 2022 | $889,000 | +101.6% | 111,658 | +41.9% | 0.00% | – |
Q4 2021 | $441,000 | +925.6% | 78,700 | +1301.6% | 0.00% | – |
Q3 2021 | $43,000 | – | 5,615 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |